Picture this: It’s a high-stakes Oval Office showdown on slashing prices for those miracle weight-loss drugs that have America collectively shedding pounds faster than a bad Tinder date. President Trump, ever the showman, is mid-announcement about making Wegovy and Zepbound affordable for the masses—because nothing says “Make America Slim Again” like subsidized skinny shots. Enter Gordon Findlay (or whoever that was—White House says it’s disputed, but we’re not here for the fine print), a pharma exec who’s probably thinking, “This deal is so good, it’s making me faint with joy.” Nope. The guy face-plants right there on live TV, slumping like a deflated whoopee cushion while Mehmet Oz heroically grabs his shoulders like a discount Dr. Oz action figure. Trump? Cool as a cucumber behind the Resolute Desk, not breaking a sweat. RFK Jr.? Bolting like he just spotted a vaccine vial. Press gets ushered out faster than a kid caught raiding the cookie jar, and the White House spins it as “just a fainting spell—back to business!” Meanwhile, obesity rates are dipping to 37%, thanks to these GLP-1 wonder drugs that cost an arm, a leg, and your firstborn without insurance. Moral of the story? Even in the room where it happens, sometimes the real drama is gravity taking a victory lap. Who needs enemies when you’ve got physics and pricey pills?
Man Collapses During Oval Office Event on Drug Prices
